{"id":998852,"date":"2026-08-28T11:06:06","date_gmt":"2026-08-28T15:06:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/"},"modified":"2026-08-28T11:06:06","modified_gmt":"2026-08-28T15:06:06","slug":"natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/","title":{"rendered":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer"},"content":{"rendered":"

<\/p>\n

Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer<\/b><\/p>\n

The partnership combines Natera’s leadership in breast cancer research and personalized molecular residual disease (MRD) testing with Susan G. Komen’s global advocacy and patient support network<\/i><\/p>\n

AUSTIN, Texas–(BUSINESS WIRE<\/a>)–
\nNatera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a national partnership with Susan G. Komen\u00ae, the world\u2019s leading breast cancer organization. Together, the organizations aim to accelerate breast cancer awareness and education, including efforts to increase understanding of MRD. Natera\u2019s SignateraTM <\/sup>MRD test is supported by more than 185 peer-reviewed publications across multiple cancer types, including breast cancer. This growing body of evidence reflects Natera’s ongoing investment in clinical research.<\/p>\n

\nSusan G. Komen is the only advocacy organization addressing breast cancer through a comprehensive approach that spans research, community health, patient support, public policy, and global outreach. The partnership complements Natera\u2019s commitment to advancing evidence generation in breast cancer, with multiple ongoing and planned studies evaluating how MRD testing may help personalize care, inform treatment decisions, and improve outcomes.<\/p>\n

\nNatera will serve as the 2026 Premier National Series Sponsor of the Susan G. Komen Race for the Cure\u00ae and MORE THAN PINK Walk\u00ae events. Through its support of Komen\u2019s nationwide series of 5K run\/walk events, Natera will help raise awareness of breast health, support patients and survivors, and advance Komen\u2019s mission to save lives. Natera will also continue to support Komen\u2019s patient education initiatives, including the \u201cKnow More\u201d series.<\/p>\n

\n\u201cOur growing partnership with Susan G. Komen reflects Natera\u2019s commitment to advancing science with urgency and ensuring that meaningful innovations reach the patients and clinicians who need them most,\u201d said Minetta Liu, M.D., chief medical officer, oncology and early cancer detection, Natera. \u201cWe are honored to support Komen\u2019s national event series and stand alongside the patients, advocates, researchers, and healthcare professionals working every day to improve outcomes for people affected by breast cancer.\u201d<\/p>\n

\nBreast cancer remains one of the most significant health challenges worldwide. In the United States, a woman is diagnosed with breast cancer approximately every two minutes, and breast cancer remains a leading cause of cancer-related death among women globally.\u00b9 While breast cancer in men is rare, accounting for less than 1% of cases, it is often diagnosed at a later stage, contributing to poorer outcomes.\u00b2<\/p>\n

\n\u201cNatera’s partnership helps strengthen our reach to fund breakthrough research, support patients and families, and deliver critical resources to communities across the country,\u201d said Victoria Wolodzko Smart, senior vice president of mission, Susan G. Komen. \u201cTogether, we can help accelerate progress against breast cancer while ensuring that people facing the disease have access to the education, support, and advocacy they need. We are grateful for Natera’s partnership and shared commitment to creating a world where no one loses their life to breast cancer.\u201d<\/p>\n

References<\/b><\/p>\n

    \n
  1. \nSusan G. Komen. Breast Cancer Fact Sheet.<\/i> Susan G. Komen. January 2026. PDF available at: https:\/\/www.komen.org\/wp-content\/uploads\/BCFactSheetOct2017-1.pdf<\/a>. Accessed March 10, 2026.<\/p>\n<\/li>\n
  2. \n\u201cMale Breast Cancer.\u201d Susan G. Komen\u00ae<\/i>, https:\/\/www.komen.org\/breast-cancer\/facts-statistics\/male-breast-cancer\/<\/a><\/li>\n<\/ol>\n

    About Natera<\/b><\/p>\n

    \nNatera\u2122 is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women\u2019s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera\u2019s tests are supported by more than 400 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. For more information, visit www.natera.com<\/a>.<\/p>\n

    About Susan G. Komen<\/b><\/p>\n

    \nSusan G. Komen\u00ae is the world\u2019s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy\u2019s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow\u2019s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org\/contact-us\/follow-us\/.<\/a><\/p>\n

    Forward-Looking Statements<\/b><\/p>\n

    \nAll statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera\u2019s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera\u2019s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to our efforts to develop and commercialize new product offerings, whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in “Risk Factors” in Natera\u2019s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com\/investors<\/a> and www.sec.gov<\/a>.<\/p>\n

    \"\"<\/p>\n

    View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260828459294\/en\/<\/a><\/span><\/p>\n

    \nInvestor Relations: Mike Brophy, CFO, Natera, Inc., investor@natera.com
    \n<\/a>
    Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc.,     pr@natera.com<\/a><\/p>\n

    KEYWORDS:<\/b> Texas United States North America<\/p>\n

    INDUSTRY KEYWORDS:<\/b> Women Biotechnology Oncology General Health Health Genetics Consumer Other Health<\/p>\n

    MEDIA:<\/b><\/p>\n\n\n\n\n
    Logo<\/b><\/font><\/td>\n<\/tr>\n
    \"Logo\"<\/td>\n<\/tr>\n
    <\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

    Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer The partnership combines Natera’s leadership in breast cancer research and personalized molecular residual disease (MRD) testing with Susan G. Komen’s global advocacy and patient support network AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a national partnership with Susan G. Komen\u00ae, the world\u2019s leading breast cancer organization. Together, the organizations aim to accelerate breast cancer awareness and education, including efforts to increase understanding of MRD. Natera\u2019s SignateraTM MRD test is supported by more than 185 peer-reviewed publications across multiple cancer types, including breast cancer. This growing body of evidence reflects Natera’s ongoing investment in clinical … <\/p>\n

    Continue reading “Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998852","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNatera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer The partnership combines Natera’s leadership in breast cancer research and personalized molecular residual disease (MRD) testing with Susan G. Komen’s global advocacy and patient support network AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a national partnership with Susan G. Komen\u00ae, the world\u2019s leading breast cancer organization. Together, the organizations aim to accelerate breast cancer awareness and education, including efforts to increase understanding of MRD. Natera\u2019s SignateraTM MRD test is supported by more than 185 peer-reviewed publications across multiple cancer types, including breast cancer. This growing body of evidence reflects Natera’s ongoing investment in clinical … Continue reading "Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T15:06:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer\",\"datePublished\":\"2026-08-28T15:06:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/\"},\"wordCount\":1023,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/\",\"name\":\"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-08-28T15:06:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer - Market Newsdesk","og_description":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer The partnership combines Natera’s leadership in breast cancer research and personalized molecular residual disease (MRD) testing with Susan G. Komen’s global advocacy and patient support network AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a national partnership with Susan G. Komen\u00ae, the world\u2019s leading breast cancer organization. Together, the organizations aim to accelerate breast cancer awareness and education, including efforts to increase understanding of MRD. Natera\u2019s SignateraTM MRD test is supported by more than 185 peer-reviewed publications across multiple cancer types, including breast cancer. This growing body of evidence reflects Natera’s ongoing investment in clinical … Continue reading \"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-28T15:06:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer","datePublished":"2026-08-28T15:06:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/"},"wordCount":1023,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/","name":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-08-28T15:06:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260828459294r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-and-susan-g-komen-announce-national-partnership-to-accelerate-progress-against-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Natera and Susan G. Komen\u00ae Announce National Partnership to Accelerate Progress Against Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998852"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998852\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}